janx011
janx011: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Janux Therapeutics, Inc. (JANX) | Early Phase 1 |
Clinical Trials (1)
A Phase 1, Open-Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of JANX011 With Optional Step-Up Dosing in Healthy Adult Volunteers
Frequently asked questions
Who is developing janx011?
janx011 is being developed by Janux Therapeutics, Inc..
How many clinical trials involve janx011?
BioSniper tracks 1 clinical trial involving janx011.
Get deeper analysis on janx011
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis